Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Comment by cloinveston Jan 29, 2019 3:55am

121 Views

Post# 29291087

RE:RE:After 2019’s reverse split -

NoBaloney wrote: This article from Equity Guru is dated May, 2018. It's older, but not much has changed. Management is still not delivering.

https://equity.guru/2018/05/31/happening-fsd-pharma-huge-c-insider-loaded-overvalued-restrictive-mess/

Same B.S article from way back in May.Old bashing nice try.

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023